مرور Volume 9, Issue 6 بر اساس تاریخ انتشار
در حال نمایش موارد 1 - 5 از 5
-
“Sell an Ox” - The Price of Cure for Hepatitis C in Two Countries
(Kerman University of Medical Sciences, 2020-06-01)Chronic hepatitis C virus (HCV) infection, associated with severe liver disease and cancer, affects 70 million people worldwide. New treatments with direct-acting-antivirals offer cure for about ...
-
Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed?; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”
(Kerman University of Medical Sciences, 2020-06-01)A recent paper by Grutters et al makes the case for early health economic modeling in the development of health technologies. A number of examples of the value of early modeling are given, with ...
-
Designing an Optimum Fiscal Policy for Tobacco to Maximise the Tax Revenue, Social Savings and the Net Monetary Benefits in Sri Lanka
(Kerman University of Medical Sciences, 2020-06-01)Background Fiscal policy targeting tobacco control is identified as the most effective strategy for rapid control of tobacco use. An optimum fiscal policy to ...
-
Achievements of the Cochrane Iran Associate Centre: Lessons Learned
(Kerman University of Medical Sciences, 2020-06-01)Healthcare decision-making is a process that mainly depends on evidence and involves increasing numbers of stakeholders, including the consumers. Cochrane evidence responds to this challenge by ...
-
Use of Evidence-Informed Deliberative Processes – Learning by Doing; Comment on “Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe”
(Kerman University of Medical Sciences, 2020-06-01)The article by Oortwijn, Jansen, and Baltussen (OJB) is much more important than it appears because, in the absence of any good general theory of “evidence-informed deliberative processes" (EDP) ...
